Related references
Note: Only part of the references are listed.Toward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome
Dilja D. Krueger et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome
Zhong-Hua Liu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Glycogen synthase kinase-3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production
Alessandra Valerio et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning
Weixiang Guo et al.
NATURE MEDICINE (2011)
RNA-Binding Protein FXR2 Regulates Adult Hippocampal Neurogenesis by Reducing Noggin Expression
Weixiang Guo et al.
NEURON (2011)
Involvement of the Glycogen Synthase Kinase-3 Signaling Pathway in TBI Pathology and Neurocognitive Outcome
Pramod K. Dash et al.
PLOS ONE (2011)
Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome
Dilja D. Krueger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome
Christopher J. Yuskaitis et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Epigenetic Regulation of miR-184 by MBD1 Governs Neural Stem Cell Proliferation and Differentiation
Changmei Liu et al.
CELL STEM CELL (2010)
The Developmental Stage of Dentate Granule Cells Dictates Their Contribution to Seizure-Induced Plasticity
Michelle M. Kron et al.
JOURNAL OF NEUROSCIENCE (2010)
Delayed Stabilization of Dendritic Spines in Fragile X Mice
Alberto Cruz-Martin et al.
JOURNAL OF NEUROSCIENCE (2010)
O2 regulates stem cells through Wnt/β-catenin signalling
Jolly Mazumdar et al.
NATURE CELL BIOLOGY (2010)
GSK3 signalling in neural development
Eun-Mi Hur et al.
NATURE REVIEWS NEUROSCIENCE (2010)
New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?
Wei Deng et al.
NATURE REVIEWS NEUROSCIENCE (2010)
GSK3 Influences Social Preference and Anxiety-Related Behaviors during Social Interaction in a Mouse Model of Fragile X Syndrome and Autism
Marjelo A. Mines et al.
PLOS ONE (2010)
MicroRNA miR-137 Regulates Neuronal Maturation by Targeting Ubiquitin Ligase Mind Bomb-1
Richard D. Smrt et al.
STEM CELLS (2010)
Fragile X Mental Retardation Protein Regulates Proliferation and Differentiation of Adult Neural Stem/Progenitor Cells
Yuping Luo et al.
PLOS GENETICS (2010)
FMR1: A gene with three faces
Ben A. Oostra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling
Yingwei Mao et al.
CELL (2009)
GENE, BRAIN, AND BEHAVIOR RELATIONSHIPS IN FRAGILE X SYNDROME: EVIDENCE FROM NEUROIMAGING STUDIES
Amy A. Lightbody et al.
DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2009)
A Functional Role for Adult Hippocampal Neurogenesis in Spatial Pattern Separation
C. D. Clelland et al.
SCIENCE (2009)
Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion
Eric R. Gross et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
GSK3β inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes
Barbara Bellei et al.
CELLULAR SIGNALLING (2008)
Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice
Fernke M. S. de Vrij et al.
NEUROBIOLOGY OF DISEASE (2008)
Endogenous Matrix Metalloproteinase (MMP)-3 and MMP-9 Promote the Differentiation and Migration of Adult Neural Progenitor Cells in Response to Chemokines
Basam Z. Barkho et al.
STEM CELLS (2008)
Thiazolidinediones modulate the expression of β-catenin and other cell-cycle regulatory proteins by targeting the F-Box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor γ
Shuo Wei et al.
MOLECULAR PHARMACOLOGY (2007)
Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice
Mansuo L. Hayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons
Richard D. Smrt et al.
NEUROBIOLOGY OF DISEASE (2007)
Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model
Kei Watase et al.
PLOS MEDICINE (2007)
Social behavior deficits in the Fmr1 mutant mouse
YS Mineur et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Neural plasticity in the ageing brain
SN Burke et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome
MG Zhao et al.
JOURNAL OF NEUROSCIENCE (2005)
Therapeutic implications of the mGluR theory of fragile X mental retardation
MF Bear
GENES BRAIN AND BEHAVIOR (2005)
GSK3 inhibitors: Development and therapeutic potential
P Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function
XY Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo
DB Ring et al.
DIABETES (2003)
New insights into fragile X syndrome: from molecules to neurobehaviors
P Jin et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
beta-catenin is critical for dendritic morphogenesis
X Yu et al.
NATURE NEUROSCIENCE (2003)
Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (falfa) rats
GW Cline et al.
DIABETES (2002)
Glycogen synthase kinase-3β inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation
J Carmichael et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death
DAE Cross et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
MP Coghlan et al.
CHEMISTRY & BIOLOGY (2000)
Share Paper
